BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao S, Wu D, Wu P, Wang Z, Huang J. Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLoS One. 2015;10:e0139598. [PMID: 26440936 DOI: 10.1371/journal.pone.0139598] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Armitage JD, Newnes HV, McDonnell A, Bosco A, Waithman J. Fine-Tuning the Tumour Microenvironment: Current Perspectives on the Mechanisms of Tumour Immunosuppression. Cells 2021;10:E56. [PMID: 33401460 DOI: 10.3390/cells10010056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yang Y, Wang S, Li T. Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis. Oncotarget 2017;8:35234-43. [PMID: 28415638 DOI: 10.18632/oncotarget.16470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Marconi R, Serafini A, Giovanetti A, Bartoleschi C, Pardini MC, Bossi G, Strigari L. Cytokine Modulation in Breast Cancer Patients Undergoing Radiotherapy: A Revision of the Most Recent Studies. Int J Mol Sci 2019;20:E382. [PMID: 30658426 DOI: 10.3390/ijms20020382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
4 Gameiro SF, Ghasemi F, Barrett JW, Koropatnick J, Nichols AC, Mymryk JS, Maleki Vareki S. DIY: Visualizing the immune landscape of tumors using transcriptome and methylome data. Methods Enzymol 2020;636:49-76. [PMID: 32178827 DOI: 10.1016/bs.mie.2019.05.040] [Reference Citation Analysis]
5 Gornati L, Zanoni I, Granucci F. Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines. Front Immunol 2018;9:1484. [PMID: 29997628 DOI: 10.3389/fimmu.2018.01484] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Tang J, Pan R, Xu L, Ma Q, Ying X, Zhao J, Zhao H, Miao L, Xu Y, Duan S, Wang J. IL10 hypomethylation is associated with the risk of gastric cancer. Oncol Lett 2021;21:241. [PMID: 33664805 DOI: 10.3892/ol.2021.12502] [Reference Citation Analysis]
7 Chen D, Huang L, Zhou H, Zhang Y. Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8+ T Cells. Front Immunol 2021;12:615089. [PMID: 33717103 DOI: 10.3389/fimmu.2021.615089] [Reference Citation Analysis]
8 Akinyemiju T, Moore JX, Pisu M, Goodman M, Howard VJ, Safford M, Gilchrist SC, Cushman M, Long L, Judd SE. Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget 2019;10:4857-67. [PMID: 31448052 DOI: 10.18632/oncotarget.27108] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Bergmann CB, Beckmann N, Salyer CE, Hanschen M, Crisologo PA, Caldwell CC. Potential Targets to Mitigate Trauma- or Sepsis-Induced Immune Suppression. Front Immunol 2021;12:622601. [PMID: 33717127 DOI: 10.3389/fimmu.2021.622601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Colombo M, Mirandola L, Chiriva-Internati M, Basile A, Locati M, Lesma E, Chiaramonte R, Platonova N. Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu. Front Immunol. 2018;9:1823. [PMID: 30154786 DOI: 10.3389/fimmu.2018.01823] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
11 Mesiano G, Zini R, Montagner G, Bianchi N, Manfredini R, Chillemi A, Aglietta M, Grignani G, Lampronti I, Fiorino E, Malavasi F, Sangiolo D, Gambari R, Ferrari D. Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells. Mol Med 2017;23:235-46. [PMID: 28805233 DOI: 10.2119/molmed.2017.00084] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Karstens KF, Kempski J, Giannou AD, Freiwald E, Reeh M, Tachezy M, Izbicki JR, Lohse AW, Gagliani N, Huber S, Pelczar P. Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas. PLoS One 2020;15:e0231833. [PMID: 32298379 DOI: 10.1371/journal.pone.0231833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 King J, Mir H, Singh S. Association of Cytokines and Chemokines in Pathogenesis of Breast Cancer. Approaches to Understanding Breast Cancer. Elsevier; 2017. pp. 113-36. [DOI: 10.1016/bs.pmbts.2017.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
14 Chang CM, Lam HYP, Hsu HJ, Jiang SJ. Interleukin-10: A double-edged sword in breast cancer. Tzu Chi Med J 2021;33:203-11. [PMID: 34386356 DOI: 10.4103/tcmj.tcmj_162_20] [Reference Citation Analysis]
15 Solís-martínez R, Cancino-marentes M, Hernández-flores G, Ortiz-lazareno P, Mandujano-álvarez G, Cruz-gálvez C, Sierra-díaz E, Rodríguez-padilla C, Jave-suárez L, Aguilar-lemarroy A, Bravo-cuellar A. Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3. Immunology Letters 2018;196:140-8. [DOI: 10.1016/j.imlet.2018.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
16 Merlano MC, Abbona A, Paccagnella M, Falletta A, Granetto C, Ricci V, Fea E, Denaro N, Ruatta F, Merlotti A, Bertetto O, Crosetto N, Galizia D, Basiricò M, Gammaitoni L, Sangiolo D, Aglietta M, Garrone O. Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy. Vaccines (Basel) 2021;9:235. [PMID: 33800511 DOI: 10.3390/vaccines9030235] [Reference Citation Analysis]
17 de la Cruz-López KG, Castro-Muñoz LJ, Reyes-Hernández DO, García-Carrancá A, Manzo-Merino J. Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches. Front Oncol 2019;9:1143. [PMID: 31737570 DOI: 10.3389/fonc.2019.01143] [Cited by in Crossref: 117] [Cited by in F6Publishing: 96] [Article Influence: 58.5] [Reference Citation Analysis]
18 Li Y, Gou H, Chu P, Zhang K, Jiang Z, Cai R, Song S, Bian Z, Li C. Comparison of Host Cytokine Response in Piglets Infected With Toxigenic and Non-toxigenic Staphylococcus hyicus. Front Vet Sci 2021;8:639141. [PMID: 33665221 DOI: 10.3389/fvets.2021.639141] [Reference Citation Analysis]
19 Rivas JR, Liu Y, Alhakeem SS, Eckenrode JM, Marti F, Collard JP, Zhang Y, Shaaban KA, Muthusamy N, Hildebrandt GC, Fleischman RA, Chen L, Thorson JS, Leggas M, Bondada S. Interleukin-10 suppression enhances T-cell antitumor immunity and responses to checkpoint blockade in chronic lymphocytic leukemia. Leukemia 2021. [PMID: 33731852 DOI: 10.1038/s41375-021-01217-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Burke JD, Young HA. IFN-γ: A cytokine at the right time, is in the right place. Semin Immunol 2019;43:101280. [PMID: 31221552 DOI: 10.1016/j.smim.2019.05.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
21 Stoll JR, Vaidya TS, Mori S, Dusza SW, Lacouture ME, Markova A. Association of interleukin-6 and tumor necrosis factor-α with mortality in hospitalized patients with cancer. J Am Acad Dermatol 2021;84:273-82. [PMID: 32171811 DOI: 10.1016/j.jaad.2020.03.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mancuso F, Lage S, Rasero J, Díaz-Ramón JL, Apraiz A, Pérez-Yarza G, Ezkurra PA, Penas C, Sánchez-Diez A, García-Vazquez MD, Gardeazabal J, Izu R, Mujika K, Cortés J, Asumendi A, Boyano MD. Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study. Mol Oncol 2020;14:1705-18. [PMID: 32485045 DOI: 10.1002/1878-0261.12732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Andersen BL, Goyal NG, Weiss DM, Westbrook TD, Maddocks KJ, Byrd JC, Johnson AJ. Cells, cytokines, chemokines, and cancer stress: A biobehavioral study of patients with chronic lymphocytic leukemia. Cancer 2018;124:3240-8. [PMID: 29757455 DOI: 10.1002/cncr.31538] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
24 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
25 Giunta EF, Barra G, De Falco V, Argenziano G, Napolitano S, Vitale P, Zanaletti N, Terminiello M, Martinelli E, Morgillo F, Ciardiello D, De Palma R, Ciardiello F, Troiani T. Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients. Sci Rep 2020;10:17626. [PMID: 33077770 DOI: 10.1038/s41598-020-72711-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
26 Buonaguro L, Mauriello A, Cavalluzzo B, Petrizzo A, Tagliamonte M. Immunotherapy in hepatocellular carcinoma. Ann Hepatol. 2019;18:291-297. [PMID: 31047849 DOI: 10.1016/j.aohep.2019.04.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
27 Sanguinete MMM, Oliveira PH, Martins-Filho A, Micheli DC, Tavares-Murta BM, Murta EFC, Nomelini RS. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer. Immunol Invest 2017;46:677-88. [PMID: 28872976 DOI: 10.1080/08820139.2017.1360342] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 14.0] [Reference Citation Analysis]
28 Santegoets SJ, Welters MJ, van der Burg SH. Monitoring of the Immune Dysfunction in Cancer Patients. Vaccines (Basel) 2016;4:E29. [PMID: 27598210 DOI: 10.3390/vaccines4030029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Pérez-Tomás R, Pérez-Guillén I. Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment. Cancers (Basel) 2020;12:E3244. [PMID: 33153193 DOI: 10.3390/cancers12113244] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
30 Ezzeddini R, Somi MH, Taghikhani M, Moaddab SY, Masnadi Shirazi K, Shirmohammadi M, Eftekharsadat AT, Sadighi Moghaddam B, Salek Farrokhi A. Association of Foxp3 rs3761548 polymorphism with cytokines concentration in gastric adenocarcinoma patients. Cytokine 2021;138:155351. [PMID: 33127257 DOI: 10.1016/j.cyto.2020.155351] [Reference Citation Analysis]
31 Dahlem C, Siow WX, Lopatniuk M, Tse WKF, Kessler SM, Kirsch SH, Hoppstädter J, Vollmar AM, Müller R, Luzhetskyy A, Bartel K, Kiemer AK. Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism. Cancers (Basel) 2020;12:E1288. [PMID: 32438733 DOI: 10.3390/cancers12051288] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
32 Chen Y, Filipov NM, Guo TL. Dietary Glycation Products Regulate Immune Homeostasis: Early Glycation Products Promote Prostate Cancer Cell Proliferation through Modulating Macrophages. Mol Nutr Food Res 2018;62. [PMID: 29082675 DOI: 10.1002/mnfr.201700641] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
33 Guerrouahen BS, Maccalli C, Cugno C, Rutella S, Akporiaye ET. Reverting Immune Suppression to Enhance Cancer Immunotherapy. Front Oncol 2019;9:1554. [PMID: 32039024 DOI: 10.3389/fonc.2019.01554] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
34 Shakiba E, Ramezani M, Sadeghi M. Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis. Clin Exp Hepatol 2018;4:35-40. [PMID: 29594196 DOI: 10.5114/ceh.2018.73484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Mantilla-Rojas C, Yu M, Rinella ES, Lynch RM, Perry A, Jaimes-Alvarado J, Anderson KR, Barba E, Bourgeois EJ, Konganti K, Threadgill DW. A molecular subtype of colorectal cancers initiates independently of epidermal growth factor receptor and has an accelerated growth rate mediated by IL10-dependent anergy. Oncogene 2021;40:3047-59. [PMID: 33767440 DOI: 10.1038/s41388-021-01752-2] [Reference Citation Analysis]
36 Shen L, Li J, Liu Q, Song W, Zhang X, Tiruthani K, Hu H, Das M, Goodwin TJ, Liu R, Huang L. Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers. ACS Nano 2018;12:9830-41. [PMID: 30253648 DOI: 10.1021/acsnano.8b00967] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
37 Do EJ, Hwang SW, Kim SY, Ryu YM, Cho EA, Chung EJ, Park S, Lee HJ, Byeon JS, Ye BD, Yang DH, Park SH, Yang SK, Kim JH, Myung SJ. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3. J Gastroenterol Hepatol. 2016;31:1453-1461. [PMID: 26711554 DOI: 10.1111/jgh.13280] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
38 McKay HS, Bream JH, Margolick JB, Martínez-Maza O, Phair JP, Rinaldo CR, Abraham AG, Jacobson LP. Host factors associated with serologic inflammatory markers assessed using multiplex assays. Cytokine 2016;85:71-9. [PMID: 27295613 DOI: 10.1016/j.cyto.2016.05.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Castro F, Pinto ML, Pereira CL, Serre K, Barbosa MA, Vermaelen K, Gärtner F, Gonçalves RM, De Wever O, Oliveira MJ. Chitosan/γ-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer. Biomaterials 2020;257:120218. [DOI: 10.1016/j.biomaterials.2020.120218] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
40 Mampay M, Flint MS, Sheridan GK. Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers. Br J Pharmacol 2021;178:3977-96. [PMID: 34029379 DOI: 10.1111/bph.15571] [Reference Citation Analysis]
41 Paciorek M, Bednarska A, Krogulec D, Makowiecki M, Kowalska JD, Bursa D, Świderska A, Puła J, Raczyńska J, Skrzat-Klapaczyńska A, Radkowski M, Demkow U, Laskus T, Horban A. Clinical Course and Outcome of Community-Acquired Bacterial Meningitis in Cancer Patients. Adv Exp Med Biol 2020;1251:49-56. [PMID: 31792808 DOI: 10.1007/5584_2019_438] [Reference Citation Analysis]
42 Siekmann W, Eintrei C, Magnuson A, Sjölander A, Matthiessen P, Myrelid P, Gupta A. Surgical and not analgesic technique affects postoperative inflammation following colorectal cancer surgery: a prospective, randomized study. Colorectal Dis 2017;19:O186-95. [PMID: 28258664 DOI: 10.1111/codi.13643] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
43 Paredes J, Ji P, Lacomb JF, Shroyer KR, Martello LA, Williams JL. Establishment of three novel cell lines derived from African American patients with colorectal carcinoma: A unique tool for assessing racial health disparity. Int J Oncol 2018;53:1516-28. [PMID: 30066857 DOI: 10.3892/ijo.2018.4510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Shan G, Tang T, Qian H, Xia Y. Certain BCG-reactive responses are associated with bladder cancer prognosis. Cancer Immunol Immunother 2018;67:797-803. [PMID: 29478100 DOI: 10.1007/s00262-018-2127-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
45 Todorović-raković N, Radulovic M, Vujasinović T, Milovanović J, Nikolić-vukosavljević D. The time-dependent prognostic value of intratumoral cytokine expression profiles in a natural course of primary breast cancer with a long-term follow-up. Cytokine 2018;102:12-7. [DOI: 10.1016/j.cyto.2017.11.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Kodar K, Mcconnell MJ, Harper JL, Timmer MS, Stocker BL. The coadministration of trehalose dibehenate and monosodium urate crystals promotes an antitumor phenotype in human‐derived myeloid cells. Immunol Cell Biol 2020;98:411-22. [DOI: 10.1111/imcb.12329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Mizandari M, Paksashvili N, Kikodze N, Azrumelashvili T, Pantsulaia I, Shanava K, Janikashvili N, Chikovani T. Long-term survival in a patient with low-level inflammatory markers and liver metastasis, converted resectable by TACE. Immunotherapy 2017;9:1067-9. [PMID: 29032738 DOI: 10.2217/imt-2017-0069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
48 Owen KL, Brockwell NK, Parker BS. JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression. Cancers (Basel) 2019;11:E2002. [PMID: 31842362 DOI: 10.3390/cancers11122002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 35.5] [Reference Citation Analysis]
49 Karagiannidis I, de Santana Van Vilet E, Said Abu Egal E, Phinney B, Jacenik D, Prossnitz ER, Beswick EJ. G-CSF and G-CSFR Induce a Pro-Tumorigenic Macrophage Phenotype to Promote Colon and Pancreas Tumor Growth. Cancers (Basel) 2020;12:E2868. [PMID: 33036138 DOI: 10.3390/cancers12102868] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Gorby C, Sotolongo Bellón J, Wilmes S, Warda W, Pohler E, Fyfe PK, Cozzani A, Ferrand C, Walter MR, Mitra S, Piehler J, Moraga I. Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses. Sci Signal 2020;13:eabc0653. [PMID: 32934073 DOI: 10.1126/scisignal.abc0653] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
51 Alotaibi MR, Hassan ZK, Al-Rejaie SS, Alshammari MA, Almutairi MM, Alhoshani AR, Alanazi WA, Hafez MM, Al-Shabanah OA. Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 Silencing. Asian Pac J Cancer Prev 2018;19:777-83. [PMID: 29582634 DOI: 10.22034/APJCP.2018.19.3.777] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
52 Donlon NE, Sheppard A, Davern M, O'Connell F, Phelan JJ, Power R, Nugent T, Dinneen K, Aird J, Greene J, Nevins Selvadurai P, Bhardwaj A, Foley EK, Ravi N, Donohoe CL, Reynolds JV, Lysaght J, O'Sullivan J, Dunne MR. Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma-An Emerging Role for Chemokines. Cancers (Basel) 2020;12:E3356. [PMID: 33202734 DOI: 10.3390/cancers12113356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]